Tuesday, February 11, 2014

Panacea Global, Inc. (PANG) Develops New Early Cancer Diagnostics Test for Worldwide Commercialization

Panacea Global, a biotech company focused on the development and commercialization of diagnostic products for the management of cancer, has developed a fully automated device for commercialization of its early cancer diagnostics test.

The company’s newly designed ELISA machine is a custom-designed, fully-automated solution to detect the presence of HAAH, a novel biomarker present in blood samples taken from cancer patients.

With minimal operator interference, ELISA manages all aspects of the test protocol with the highest degree of conformity. Panacea Global reports that the device has the automation capability to manage more than 1,000 patients per day. A series of hardware and accompanying software designed to achieve accuracy and reproducibility at the highest level.

“The newly developed customized and automated system will allow Panacea Global commercialization of our cutting-edge early cancer marker on a global scale,” Panacea President and CEO Mahmood Moshiri stated in the news release. “The device will allow us and our partners to saves time and resources, eliminate human errors, and ensure high-quality results. Furthermore, the automation allows for stronger management of patient identification throughout the process. This reduces the opportunity for misdiagnosis and mislabeling.”

For more information, visit www.panaceaglobalinc.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: